Metabolic Alkalosis Treatment Standard.

cystic fibrosis transmembrane conductance regulator metabolic alkalosis pendrin

Journal

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
ISSN: 1460-2385
Titre abrégé: Nephrol Dial Transplant
Pays: England
ID NLM: 8706402

Informations de publication

Date de publication:
04 Sep 2024
Historique:
medline: 5 9 2024
pubmed: 5 9 2024
entrez: 4 9 2024
Statut: aheadofprint

Résumé

The kidney is poised to defend against development of metabolic alkalosis through non-adaptive mechanisms in the proximal nephron and adaptive processes in the distal nephron. Despite a prodigious capacity to excrete base, metabolic alkalosis is the most common acid-base disturbance in hospitalized patients. Development of this disorder requires pathophysiologic changes leading to generation of new HCO3- combined with an augmentation in the capacity of the kidney to reclaim filtered HCO3-. The initial approach to these patients is careful assessment of effective arterial blood volume focusing on the physical examination and urine electrolytes. Identifying the mechanisms by which the kidney's ability to correct alkalosis are perturbed provides an understanding of the clinical approach to differential diagnosis and appropriate treatment. While metabolic alkalosis is frequently not dangerous, in certain settings, metabolic alkalosis may contribute to mortality and should be aggressively managed.

Identifiants

pubmed: 39231806
pii: 7749588
doi: 10.1093/ndt/gfae195
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the ERA.

Auteurs

Biff F Palmer (BF)

Texas Tech Health Sciences Center, El Paso, TX.

Deborah J Clegg (DJ)

Texas Tech Health Sciences Center, El Paso, TX.

Classifications MeSH